Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
The latest in regenerative medicine is here
They capture antigens and present them to T cells, essentially telling the immune system what to attack
About the study The phase 3a, multicenter, randomized, double-blind, placebo- and active-controlled REDEFINE 1 trial enrolled 3,417 adults across 22 countries
The remaining 25 articles were included in the qualitative synthesis, and 16 in the quantitative synthesis (Figure 1)
US$ 20.09
US$ 20.60
US$ 21.45
US$ 26.62
